The Week with the NBER Paper Situation This week saw the emergence of a spicy controversy surrounding an NBER working paper which concluded that Indian firms differentiate drug quality based on destination of consumption, to the detriment of African countries. The Indian government had a shocking response to this working paper – they decided to sue for defamation. We carried a set of posts to cover this whirlwind situation, one on the conclusions in the paper itself, followed up by...
↧